Commercialization and Manufacturing
Devyn Smith,
Head of Business Operations and Strategy, Medicinal Sciences Division,
Pfizer
Is commercializing cell therapies similar to traditional small molecules or biologics? What are the core similarities? What are key differences? It is critical to understand a potential product’s commercialization strategy early enough to influence the product and clinical development strategies. The impact of these strategies downstream on a product will be reviewed in a case study.
|
|
